ZLAB – zai lab limited - american depositary shares (US:NASDAQ)
Stock Stats
News
Zai Lab (NASDAQ:ZLAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $46.00 to $39.00. They now have an "overweight" rating on the stock.
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025 [Seeking Alpha]
UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform [Yahoo! Finance]
Zai Lab (NASDAQ:ZLAB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Zai Lab (NASDAQ:ZLAB) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form SCHEDULE 13G/A Zai Lab Ltd Filed by: FMR LLC
Form 4 Zai Lab Ltd For: Dec 30 Filed by: Amado Rafael
Form 144 Zai Lab Ltd Filed by: Amado Rafael
Form 4 Zai Lab Ltd For: Dec 16 Filed by: Edmondson Frazor Titus III
Form 144 Zai Lab Ltd Filed by: Edmondson Frazor Titus III
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.